Does Rallies show 13F holders for INSP?

Yes. Rallies tracks hedge fund and 13F ownership data for INSP, including fund names, share counts, latest tracked quarter, and position changes when available.

Is INSP research on Rallies investment advice?

No. Rallies provides research, data, and educational context for INSP. It does not provide personalized investment advice.

INSP (Inspire Medical Systems, Inc.) Stock Analysis - Hedge Fund Holdings

Inspire Medical Systems, Inc. (INSP) is a publicly traded Healthcare sector company. As of May 21, 2026, INSP trades at $44.14 with a market cap of $1.21B and a P/E ratio of 9.83. INSP moved +3.76% today. Year to date, INSP is -53.42%; over the trailing twelve months it is -70.58%. Its 52-week range spans $39.61 to $216.01. Analyst consensus is neutral with an average price target of $54.36. Rallies surfaces INSP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns INSP stock?

Hedge funds tracked by Rallies that own INSP include Dragoneer Investment, Bridgewater Associates, Eisler Capital, Eisler Capital, and Centerbook Partners. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Inspire Medical Systems, Inc..

INSP Key Metrics

Key financial metrics for INSP
Metric	Value
Price	$44.14
Market Cap	$1.21B
P/E Ratio	9.83
EPS	$4.46
Dividend Yield	0.00%
52-Week High	$216.01
52-Week Low	$39.61
Volume	0
Avg Volume	0
Revenue (TTM)	$915.25M
Net Income	$131.14M
Gross Margin	85.78%

Top Hedge Funds Holding INSP

Dragoneer Investment holds 2.35M shares of INSP, changed +81.44% as of Jun 30, 2025.
Bridgewater Associates holds 173.53K shares of INSP, changed +141.94% as of Mar 31, 2026.
Eisler Capital holds 21.66K shares of INSP, changed +0.00% as of Jun 30, 2024.
Eisler Capital holds 5.60K shares of INSP, changed +0.00% as of Dec 31, 2023.
Centerbook Partners holds 4.13K shares of INSP, changed -34.40% as of Mar 31, 2025.

Latest INSP News

Inspire Medical Systems Downgraded Despite $204.5M Q1 Revenue and $0.10 EPS — May 5, 2026
Inspire Medical Systems Q1 Revenue Rises 1.6% to $204.6M, Guides $825–875M — May 4, 2026
Inspire Medical Systems Shares Drop 7.5% After 0.5% PPI Surge — Feb 27, 2026
Inspire Medical Systems Shares Surge 19.7% on New CMS C-Codes for Inspire V — Feb 26, 2026
Inspire Medical Systems Confronts Reimbursement Headwinds as Price Target Falls to $95 — Feb 15, 2026

Recent INSP Insider Trades

Rondoni John sold 109 (~$10.90K) on Jan 9, 2026.
mcCormick Shawn sold 1.20K (~$166.80K) on Dec 2, 2025.
mcCormick Shawn sold 2.00K (~$254.96K) on Nov 28, 2025.

INSP Analyst Consensus

13 analysts cover INSP: 0 strong buy, 3 buy, 10 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $54.36.

Common questions about INSP

Who owns INSP stock?: Hedge funds tracked by Rallies that own INSP include Dragoneer Investment, Bridgewater Associates, Eisler Capital, Eisler Capital, and Centerbook Partners. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Inspire Medical Systems, Inc..
Does Rallies show 13F holders for INSP?: Yes. Rallies tracks hedge fund and 13F ownership data for INSP, including fund names, share counts, latest tracked quarter, and position changes when available.
Is INSP research on Rallies investment advice?: No. Rallies provides research, data, and educational context for INSP. It does not provide personalized investment advice.